Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

Market Cap	1.76B
Revenue (ttm)	1.13B
Net Income (ttm)	601.19M
Shares Out	1.50B
EPS (ttm)	0.40
PE Ratio	2.93
Forward PE	n/a
Dividend	0.06 (5.38%)
Ex-Dividend Date	May 27, 2025

Volume	664,000
Average Volume	256,700
Open	1.180
Previous Close	1.170
Day's Range	1.170 - 1.220
52-Week Range	1.070 - 1.400
Beta	0.59
RSI	48.94
Earnings Date	May 23, 2025

About HKG:2348

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 1,183
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2348

Financial Performance

In 2024, HKG:2348's revenue was 1.06 billion, a decrease of -7.89% compared to the previous year's 1.15 billion. Earnings were 564.94 million, an increase of 73.29%.

Financial numbers in CNY